Stock Option

Genome&Company

314130·KOSDAQ·14 grantsAmendments merged

Shares granted, cumulative
2,766,468shares
Next lockup release
D-222
2027-03-29

Against the share price

At the 2026-08-18 close
KRW
-8.44%
Shares with a reason to exercise
2,115,568 shares
4.05% of shares outstanding
Sellable right now
804,460 shares
38% of the shares with a reason to exercise
Unrealized paper gain (to the employees)
₩3.1B

Potential dilution

5.29%Against the 15% cap

Shares by strike price

  • ₩42.2K–₩45.8K6K shares
  • ₩17K–₩20.6K10K shares
  • ₩13.4K–₩17K9K shares
  • ₩9.8K–₩13.4K386K shares
  • ₩6.2K–₩9.8K230K shares
  • ₩2.6K–₩6.2K2.1M shares
  • ₩4,230Latest price

Every strike price is above the latest close, so no options currently have a reason to be exercised.

Options the share price has risen past gain a reason to be exercised and sold once the lockup ends. Filings do not show what has already been exercised or forfeited, so these figures are on a cumulative grants basis and the shares actually outstanding may be fewer.

Share price vs. strike price

A strike price is fixed on the grant date; only the share price moves. Where the price line crosses a dashed line is when that block of options first had a reason to be exercised.

Close ₩4,2302025-08-14 ~ 2026-08-18
  • Strike ₩2,5601.2M sharesabove
  • Strike ₩3,040804K sharesabove
  • Strike ₩11,600202K shares
  • Strike ₩10,070117K shares

Recipients by role

2.8MShares granted
  • Registered director2 people33%
  • Unregistered officer7 people19%
  • Employee152 people47%

Sorted from the relation text written in the filings (161 recipients). Officers of affiliates and subsidiaries are counted as unregistered officers.

Shares granted by year

341K
87K
9K
105K
10K
804K
1.2M
200K
'19
'20
'21
'22
'23
'24
'25
'26

Cumulative grants per recipient

8 named · 151 withheld
Largest holder홍유석Registered director
Top holder 21.7%Top 3 42.3%
RecipientShares, cumulativePaper gain
600,00021.7%₩1B
320,00011.6%₩534.4M
250,0009.0%₩230.5M
160,0005.8%—
96,0003.5%₩114.2M
80,0002.9%₩95.2M
64,0002.3%₩76.2M
48,0001.7%₩57.1M
1,148,46841.5%₩1B

Recipients granted less than 10 in 10,000 of total shares issued have their names withheld under the disclosure rules; they cannot be split apart, so they are grouped into one row. Rows that pack several people onto one line, such as “OOO and 6 others”, are grouped there too, with the headcount read from that text — the split between them is never disclosed, so “my share” can only be prefilled with the per-person average. Filings carry no employee number or year of birth, so people with the same name are added together as one. “Exercisable” counts shares whose lockup has already ended, and any paper gain accrues to the employees holding the options.

Every figure here is parsed mechanically from the original DART filing (document.xml). “Exercise starts (estimated)” means the filing did not state an exercise period, so the date is the grant date plus two years under Article 340-2(4) of the Korean Commercial Act and may differ from the actual terms. Always read the original filing before making any decision.